Zimmer Biomet (ZBH) PT Lowered to $121 at Citi
Tweet
Share
E-mailGet Alerts ZBH Hot Sheet
Price: $90.88 -3.3%
Rating Summary:
18 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
18 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
Citi lowered its price target on Zimmer Biomet (NYSE: ZBH) to $121.00 (from $132.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
- Evolution Mining Ltd. (EVN:AU) (CAHPF) PT Lowered to AUD12.50 at RBC Capital
- Citi initiates coverage of Maze Therapeutics with Buy rating
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
